A month after Joe Biden laid out a plan for Americans to get a vaccine booster shot to help contain the coronavirus pandemic and the deadly Delta variant, a pivotal advisory panel to the Food and Drug Administration today partially kicked the legs out from the President’s proposal.In a whirlwind of mixed messages, the 18-member scientific committee voted 16-2 against distribution of a third shot of Pfizer’s Covid-19 vaccine for those 16 and older.
Specifically the question on the pharmaceutical giant’s application poised to the group of outside experts on Friday was: “Do the safety and effectiveness data from clinical trial C4591001 support approval of a COMIRNATY booster dose administered at least 6 months after completion of the primary
Read more on deadline.com